Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
237.00    0.00 (0.00%)
Bid:
232.00
Ask:
242.00
Spread: 10.00 (4.31%)
Market Cap: £58.41m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Interest Payment on Loan Notes

1 Aug 2016 09:48

RNS Number : 8167F
EPE Special Opportunities PLC
01 August 2016
Β 

Β 

Β 

Β 

Β 

Β 

Β 

EPE Special Opportunities plc

Β 

Interest Payment on Convertible Loan Notes (CLN) due 2016 and

on Unsecured Loan Notes (ULN) due 2022

Β 

EPE Special Opportunities plc ('the Company') is pleased to announce that pursuant to RNS Number 4489K made on 15 July 2011, the Company has today paid interest due to Convertible Loan Note holders of Β£0.0375 per CLN with a record date of 8 July 2016.

Β 

The Company further announces that pursuant to RNS Number 9641T made on 24 July 2016, the Company has today paid interest due to Unsecured Loan Note holders of Β£0.0375 per ULN with a record date of 8 July 2016.

Β 

Β 

Β 

Β 

Enquiries:

Β 

EPIC Private Equity LLP

Alex Leslie Tel: +44 (0) 207 269 8865

Β 

FIM Capital Limited

Philip Scales Tel: +44 (0) 1624 681 250

Numis Securities Ltd Tel: +44 (0) 20 7260 1000

Nominated Adviser / Corporate Adviser: Stuart Skinner / Hugh Jonathan

Corporate Broker: Charles Farquhar

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCPBMPTMBIMMFF
Date   Source Headline
16th Oct 202510:15 amRNSAnnouncement of Ordinary and ZDP Share Buybacks
23rd Sep 20257:00 amRNSNet Asset Value(s)
9th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSPortfolio Update
8th Aug 20254:00 pmRNSUpdate on Share Buy Backs
25th Jul 20255:00 pmRNSHolding(s) in Company
24th Jul 20256:00 pmRNSInterest Payment on Unsecured Loan Notes
14th Jul 20251:00 pmRNSNet Asset Value(s)
10th Jul 20257:15 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 202510:00 amRNSInvestment
30th Jun 20257:00 amRNSChange of Nominated Adviser
27th Jun 20258:00 amRNSResults of Annual General Meeting
26th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:30 amRNSTransaction in Own Shares
17th Jun 20251:00 pmRNSNet Asset Value(s)
13th Jun 20251:00 pmRNSProposed Extension of Unsecured Loan Notes
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 202511:57 amRNSTransaction in Own Shares
29th May 20255:30 pmRNSTransaction in Own Shares
28th May 20257:15 amRNSHolding(s) in Company
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20255:30 pmRNSNotice of Annual General Meeting
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20253:00 pmRNSNet Asset Value(s)
15th May 20257:15 amRNSHolding(s) in Company
15th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:15 amRNSAnnual Financial Report
2nd May 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSNet Asset Value(s)
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:20 amRNSTransaction in Own Shares
14th Apr 20257:10 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
14th Apr 20257:00 amRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20251:00 pmRNSAnnouncement of Share Buy Backs
26th Mar 20257:00 amRNSAnnual Financial Report
25th Feb 20251:00 pmRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTrading Statement
4th Feb 20257:00 amRNSInterest Payment on Unsecured Loan Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.